0001209191-17-045116.txt : 20170713 0001209191-17-045116.hdr.sgml : 20170713 20170713193942 ACCESSION NUMBER: 0001209191-17-045116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170711 FILED AS OF DATE: 20170713 DATE AS OF CHANGE: 20170713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: G1 Therapeutics, Inc. CENTRAL INDEX KEY: 0001560241 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263648180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 T.W. ALEXANDER DRIVE STREET 2: 4501 RESEARCH COMMONS, SUITE 100 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-213-9835 MAIL ADDRESS: STREET 1: P. O. BOX # 110341 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: G-Zero Therapeutics, Inc. DATE OF NAME CHANGE: 20121012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUDNICK SETH CENTRAL INDEX KEY: 0001184420 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38096 FILM NUMBER: 17964324 MAIL ADDRESS: STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101 STREET 2: C/O ARALEZ PHARMACEUTICALS CITY: MISSISSAUGA STATE: A6 ZIP: L5N 0E4 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-11 0 0001560241 G1 Therapeutics, Inc. GTHX 0001184420 RUDNICK SETH C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 1 0 0 0 Stock Option (right to buy) 15.55 2017-07-11 4 A 0 20000 0.00 A 2027-07-11 Common Stock 20000 20000 D The stock option will vest in thirty-six monthly installments at the end of each successive month following July 11, 2017, subject to the Reporting Person's continued service as a director. /s/ Caroline G. Gammill, Attorney-in-Fact 2017-07-13